On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Anaxomics Biotech SL's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€3.8M · 9 projects
- Horizon 2020€2.7M · 12 projects
- Horizon Europe€18k · 3 projects
Projects
24 EU-funded projects, newest first. Each links to the official record.
- CarrerasPathfindersAssociated partner
Enabling the next generation in search of blood cancer cures
Horizon Europe · 2024–2029 · Project on CORDIS ↗
- CarrerasLeadersAssociated partner
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- halt-RONINPartner
Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€18ktheir share - PROTrEINPartner
Computational Proteomics Training European Innovative Network
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€251ktheir share - RECOGNISEDPartner
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€71ktheir share - SMA-TBPartner
A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€428ktheir share - DISCOvERIEPartner
Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€167ktheir share - SECRETPartner
Exploitation of the SECRETory pathway for cancer therapy to address European research
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share - proEVLifeCyclePartner
The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share - HELICALPartner
HEalth data LInkage for ClinicAL benefit
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share - LEGACyPartner
CeLac and European consortium for a personalized medicine approach to Gastric Cancer
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€275ktheir share - COSMICPartner
COmbatting disorders of adaptive immunity with Systems MedICine
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€248ktheir share - DRIVEPartner
Driving next generation autophagy researchers towards translation
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€248ktheir share - TREATMENTPartner
Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia
Horizon 2020 · 2017–2021 · Project on CORDIS ↗
- LIVERHOPEPartner
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
Horizon 2020 · 2017–2023 · Project on CORDIS ↗
€224ktheir share - INDOXPartner
Optimized oxidoreductases for medium and large scale industrial biotransformations
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€349ktheir share - TRIGGERPartner
King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€300ktheir share - COMBIMSPartner
A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis
FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗
€299ktheir share - SYSMALVACPartner
Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria
FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗
€295ktheir share - SYSTEMAGEPartner
Early warning signals of ageing in human stem cells and age-related disorders
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€1.4Mtheir share - VISIONPartner
Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€466ktheir share - RAPIDPartner
Rheumatoid Arthritis and Periodontal Inflammatory Disease (RAPID)
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€228ktheir share - GUMS AND JOINTSPartner
Protein citrullination as a link between periodontal diseases and rheumatoid arthritis (RA) and target for development of novel drugs to treat RA
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€161ktheir share - ANTIPATHOGNPartner
Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€232ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 11 shared projects
- Karolinska InstitutetSweden · 5 shared projects
- Universitetet i OsloNorway · 5 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 4 shared projects
- University of GlasgowUnited Kingdom · 4 shared projects
- Stichting Amsterdam UmcNetherlands · 4 shared projects
- Deutsches Krebsforschungszentrum HeidelbergGermany · 4 shared projects
- Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 4 shared projects
- Fundacio Institut de Recerca Biomedica (Irb Barcelona)Spain · 4 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 3 shared projects
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 3 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 3 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
- The University of BirminghamUnited Kingdom · 3 shared projects
- Eberhard Karls Universitaet TuebingenGermany · 3 shared projects
- Universidad Pompeu FabraSpain · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- autoimmune diseases
- bacteriology
- biocatalysis
- biochemistry
- cardiovascular diseases
- cell biology
- cell polarity
- clinical microbiology
- colorectal cancer
- data protection
- data science
- databases
- diabetes
- drug discovery
Anaxomics Biotech SL is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
